Xiamen Kingdomway Group (002626.SZ): Received a certificate for one invention patent.

On May 9, Gelonghui reported that Xiamen Kingdomway Group (002626.SZ) announced that the company and its subsidiaries, Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. and Kingdomway Biotechnology (Jiangsu) Co., Ltd., recently received an invention patent certificate issued by the National Intellectual Property Administration for a chitosan resin adsorbent made from zeolite perlite powder and its preparation method and transparency.

Gelonghui FinanceMay 9 16:31

Kim Dawei: First Quarter Report 2025

SZSIApr 29 00:00 · Announcements

Express News | The Xiamen Securities Regulatory Bureau promotes the high-quality development of listed companies in its jurisdiction through regular visits and a mechanism for addressing concerns.

BreakingsApr 26 16:46

Express News | Xiamen Kingdomway Group: obtained 2 invention patent certificates.

BreakingsApr 10 16:48

Xiamen Kingdomway Group (002626.SZ): The recent increase in tariffs by the USA will not have a significant impact on the company's production and operation.

On April 10, Gelonghui reported that Xiamen Kingdomway Group (002626.SZ) announced that on April 2, 2025, USA President Trump declared a "reciprocal tariff" policy and signed a presidential executive order, increasing tariffs by 34% on products originating from China, as well as imposing an additional 50% higher "reciprocal tariff" starting from April 9, 2025. Xiamen Kingdomway Group Co., Ltd. (hereinafter referred to as "the company") continues to closely monitor policy developments. Based on a preliminary assessment combined with the company's actual business situation, this increase in tariffs by the USA is not expected to have a significant impact on the company's production and operations.

Gelonghui FinanceApr 10 11:52

Express News | Xiamen Kingdomway Group: The USA's new tariff policy has a limited impact on the company.

BreakingsApr 10 11:44